Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact – both negative and positive – of COVID-19 on the insulin pens, syringes, pumps and injectors devices and equipment industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. This includes revised market numbers according to the effects of the coronavirus and the expected insulin pens, syringes, pumps and injectors devices and equipment market growth numbers 2021-2030.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-global-market-report
The Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global insulin pens, syringes, pumps and injectors devices and equipment market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030. The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2021 covers insulin pens, syringes, pumps and injectors devices and equipment market drivers, insulin pens, syringes, pumps and injectors devices and equipment market trends, insulin pens, syringes, pumps and injectors devices and equipment market growth rate, insulin pens, syringes, pumps and injectors devices and equipment market major players, player-adopted strategies in the market, and insulin pens, syringes, pumps and injectors devices and equipment market size.
The global insulin pens, syringes, pumps and injectors market is expected to grow from $16.1 billion in 2019 to $17.8 billion in 2020 at a compound annual growth rate (CAGR) of 10.7%. The growth is mainly due to the COVID-19 outbreak as people with diabetes are at increased risk of serious illness from COVID-19. The diabetic care devices are increasingly being used by care providers and patients (self-monitor) to frequently check the blood glucose levels. FDA issued guidance to expand the availability and capability of non-invasive remote monitoring devices including continuous glucose monitors (CGM) during the COVID-19 pandemic. However, the growth is not as significant as expected due to the demand and supply gaps. The market is then expected to grow at a CAGR of 7.9% from 2021 and reach $21.9 billion in 2023.
Request For The Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3405&type=smp
The report covers the insulin pens, syringes, pumps and injectors devices and equipment market segments-
1) By Type: Pens, Injectors And Pumps, Syringes.
2) By End Users: Hospitals, Homecare, Others.
3) By Pens: Reusable, Disposable.
4) By Pumps: Tubed Pumps, Tubeless Pumps.
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
